234
WANG ET AL.
(S)-2-((R)-1-(4-Bromophenyl)-2-nitroethyl)
(S)-2-((S)-1-(Furan-2-yl)-2-nitroethyl)cyclohexanone (3l)
[a]D20 5 2 7.5 (c 0.24, CH2Cl2), 1H NMR (400 MHz, CDCl3): d 5 7.34–
7.33 (m, 1H), 6.29–6.28 (m, 1H), 6.18 (d, J 5 3.2Hz, 1H), 4.79 (dd, J 5
12.4, 4.8 Hz, 1H), 4.67 (dd, J 5 12.4, 9.2 Hz, 1H), 3.97 (td, J 5 9.2, 4.8
Hz, 1H), 2.79–2.72 (m, 1H), 2.48–2.32 (m, 2H), 2.13–2.07 (m, 1H), 1.85–
1.83 (m, 1H), 1.79–1.73 (m, 1H), 1.68–1.62 (m, 2H), 1.34–1.23 (m, 1H).
The enantiometric excess was determined by HPLC with a Chiralpak
AS-H column (hexane:2-propanol 5 90:10, k 5 208 nm, 0.7 ml/min); tR
(major enantiomer) 5 13.24 min, tR (minor enantiomer) 5 15.81 min,
91% ee.
cyclohexanone (3f)
[a]D20 5 2 12.3 (c 0.24, CH2Cl2), 1H NMR (400 MHz, CDCl3): d 5 7.45
(d, J 5 8.4 Hz, 2H), 7.06 (d, J 5 8.4 Hz, 2H), 4.93 (dd, J 5 12.4, 4.4 Hz,
1H), 4.60 (dd, J 5 12.4, 10.0 Hz, 1H), 3.75 (td, J 5 10.0, 4.4 Hz, 1H),
2.68–2.61 (m, 1H), 2.51–2.49 (m, 1H), 2.38–2.33 (m, 1H), 2.13–2.06 (m,
1H), 1.83–1.52 (m, 4H), 1.28–1.18 (m, 1H). The enantiometric excess
was determined by HPLC with a Chiralpak AS-H column (hexane:2-pro-
panol 5 90:10, k 5 208 nm, 1.0 ml/min); tR (minor enantiomer) 5 16.34
min, tR (major enantiomer) 5 28.70 min, 93% ee.
(S)-2-((S)-2-Nitro-1-(thiophen-2-yl)ethyl)cyclohexanone
(S)-2-((R)-1-(3-Chlorophenyl)-2-nitroethyl)
(3m)
cyclohexanone (3g)
[a]D20 5 2 14.5 (c 0.25, CH2Cl2), 1H NMR (400 MHz, CDCl3): d 5
7.22–7.21 (m, 1H), 6.93 (dd, J 5 4.8, 3.2 Hz, 1H), 6.88–6.87 (m, 1H), 4.89
(dd, J 5 12.8, 4.8 Hz, 1H), 4.65 (dd, J 5 12.8, 9.2 Hz, 1H), 4.13 (td, J 5
9.2, 4.8 Hz, 1H), 2.72–2.65 (m, 1H), 2.49–2.33 (m, 2H), 2.13–2.08 (m, 1H),
1.93–1.82 (m, 2H), 1.71–1.57 (m, 2H), 1.38–1.28 (m, 1H). The enantiomet-
ric excess was determined by HPLC with a Chiralpak AD-H column
(hexane:2-propanol 5 95:5, k 5 208 nm, 1.0 ml/min); tR (minor enan-
tiomer) 5 15.49 min, tR (major enantiomer) 5 17.80 min, 89% ee.
[a]D20 5 2 13.1 (c 0.58, CH2Cl2), 1H NMR (400 MHz, CDCl3): d 5
7.27–7.25 (m, 2H), 7.18–7.17 (m, 1H), 7.09–7.06 (m, 1H), 4.94 (dd, J 5
12.8, 4.4 Hz, 1H), 4.61 (dd, J 5 12.8, 10.0 Hz, 1H), 3.76 (td, J 5 10.0, 4.4
Hz, 1H), 2.69–2.63 (m, 1H), 2.51–2.34 (m, 2H), 2.11–2.07 (m, 1H), 1.83–
1.68 (m, 2H), 1.67–1.60 (m, 2H), 1.29–1.19 (m, 1H). The enantiometric
excess was determined by HPLC with
a Chiralpak AS-H column
(hexane:2-propanol 5 80:20, k 5 208 nm, 1.0 ml/min); tR (minor enan-
tiomer) 5 10.34 min, tR (major enantiomer) 5 17.49 min, 91% ee.
(S)-2-((S)-3-Methyl-1-nitrobutan-2-yl)cyclohexanone (3n)
1
[a]D20 5 2 6.3 (c 0.25, CH2Cl2), H NMR (400 MHz, CDCl3): d 5 4.64
(S)-2-((R)-1-(2,4-Dichlorophenyl)-2-
(dd, J 5 13.6, 5.6 Hz, 1H), 4.36 (dd, J 5 13.6, 4.8 Hz, 1H), 2.66–2.61 (m,
1H), 2.42–2.29 (m, 3H), 2.14–2.06 (m, 2H), 1.97–1.89 (m, 2H), 1.74–1.58
(m, 3H), 0.94 (d, J 5 6.8 Hz, 3H), 0.90 (d, J 5 6.8 Hz, 3H). The enantio-
metric excess was determined by HPLC with a Chiralpak AD-H column
(hexane:2-propanol 5 90:10, k 5 208 nm, 1.0 ml/min); tR (minor enan-
tiomer) 5 5.93 min, tR (major enantiomer) 5 6.90 min, 95% ee.
nitroethyl)cyclohexanone (3h)
[a]D20 5 2 41.0 (c 0.26, CH2Cl2), 1H NMR (400 MHz, CDCl3) d 5 7.41
(d, J 5 2.1 Hz, 1H), 7.25–7.17 (m, 2H), 4.92–4.87 (m, 2H), 4.27–4.21 (m,
1H), 2.91–2.84 (m, 1H), 2.51–2.45 (m, 1H), 2.42–2.32 (m, 1H), 2.14–2.09
(m, 1H), 1.88–1.81 (m, 1H), 1.77–1.58 (m, 3H), 1.39–1.26 (m, 1H). The
enantiometric excess was determined by HPLC with a Chiralpak AD-H
column (hexane:2-propanol 5 90:10, k 5 208 nm, 1.0 ml/min); tR (minor
enantiomer) 5 8.31 min, tR (major enantiomer) 5 10.67 min, 93% ee.
(R)-Tetrahydro-3-((R)-2-nitro-1-phenylethyl)
pyran-4-one (4a)
[a]D20 5 2 24.2 (c 5 0.55, CH2Cl2), 1H NMR (400 MHz, CDCl3): d 5
7.36–7.28 (m, 3H), 7.20–7.18 (m, 2H), 4.93 (dd, J 5 12.8, 4.4 Hz, 1H), 4.65
(dd, J 5 12.8, 10.0 Hz, 1H), 4.17–4.11 (m, 1H), 3.86–3.74 (m, 2H), 3.70
(ddd, J 5 11.6, 5.6, 1.2 Hz, 1H), 3.27 (dd, J 5 11.6, 8.8 Hz, 1H), 2.91–2.85
(m, 1H), 2.70–2.63 (m, 1H), 2.59–2.54 (m, 1H).The enantiometric excess
was determined by HPLC with a Chiralpak AD-H column (hexane:2-pro-
panol 5 90:10, k 5 208 nm, 1.0 ml/min); tR (minor enantiomer) 5 11.49
min, tR (major enantiomer) 5 19.79 min, 70% ee.
(S)-2-((R)-1-(2-Bromophenyl)-2-nitroethyl)
cyclohexanone (3i)
[a]D20 5 2 12.1 (c 0.25, CH2Cl2), 1H NMR (400 MHz, CDCl3): d 57.58
(dd, J 5 8.0, 1.2 Hz, 1H), 7.32–7.28 (m, 1H), 7.22 (dd, J 5 7.6, 1.6 Hz,
1H), 7.13 (td, J 5 7.6, 1.6 Hz, 1H), 4.96–4.85 (m, 2H), 4.33–4.28 (m, 1H),
2.91 (s, 1H), 2.51–2.32 (m, 3H), 2.14–2.08 (m, 1H), 1.90–1.65 (m, 4H),
1.43–1.26 (m, 1H). The enantiometric excess was determined by HPLC
with a Chiralpak AS-H column (hexane:2-propanol 5 90:10, k 5 208 nm,
0.8 ml/min); tR (minor enantiomer) 5 17.95 min, tR (major enantiomer)
5 23.55 min, 95% ee.
(4S, 5R)-4-Methyl-6-nitro-5-phenylhexan-3-one (4b)
[a]D20 5 7.5 (c 5 0.12, CH2Cl2), 1H NMR (400 MHz, CDCl3): d 5 7.35–
7.28 (m, 3H), 7.17–7.15 (m, 2H), 4.67 (dd, J 5 12.4, 8.8 Hz, 1H), 4.60
(dd, J 5 12.4, 4.8 Hz, 1H), 3.70 (td, J 5 9.2, 4.8 Hz, 1H), 3.02–2.96 (m,
1H), 2.66–2.56 (m, 1H), 2.46–2.36 (m, 1H), 1.07 (t, J 5 7.2 Hz, 3H), 0.97
(d, J 5 7.2 Hz, 3H). The enantiometric excess was determined by HPLC
with a Chiralpak OD-H column (hexane:2-propanol 5 97:3, k 5 210 nm,
0.5 ml/min); tR (major enantiomer) 5 42.05 min, tR (minor enantiomer)
5 53.73 min, 92% ee.
(S)-2-((R)-2-Nitro-1-(2-nitrophenyl)ethyl)
cyclohexanone (3j)
[a]D20 5 2 54.2 (c 0.38, CH2Cl2), 1H NMR (400 MHz, CDCl3): d 5 7.84
(dd, J 5 8.0, 1.2 Hz, 1H), 7.59 (td, J 5 7.6, 1.2 Hz, 1H), 7.47–7.42 (m,
2H), 4.98–4.90 (m, 2H), 4.33 (td, J 5 8.8, 5.2 Hz, 1H), 2.98–2.91 (m, 1H),
2.50–2.35 (m, 2H), 2.15–2.09 (m, 1H), 1.87–1.79 (m, 2H), 1.72–1.43 (m,
3H). The enantiometric excess was determined by HPLC with a Chiral-
pak AD-H column (hexane:2-propanol 5 95:5, k 5 208 nm, 0.9 ml/min);
tR (minor enantiomer) 5 34.23 min, tR (major enantiomer) 5 47.31 min,
95% ee.
(R)-5-Nitro-4-phenylpentan-2-one (4c)
[a]D20 5 2 4.5 (c 0.24, CH2Cl2), 1H NMR (400 MHz, CDCl3): d 5 7.35–
7.02 (m, 5H), 4.69 (dd, J 5 12.4, 6.8 Hz, 1H), 4.60 (dd, J 5 12.4, 7.6 Hz,
1H), 4.04–3.97 (m, 1H), 2.92 (d, J 5 6.8 Hz, 2H), 2.11 (s, 3H). The enan-
tiometric excess was determined by HPLC with a Chiralpak AS-H col-
umn (hexane:2-propanol 5 80:20, k 5 208 nm, 1.0 ml/min); tR (minor
enantiomer) 5 13.28 min, tR (major enantiomer) 5 14.64 min, 48% ee.
(S)-2-((R)-1-(Naphthalen-1-yl)-2-nitroethyl)
cyclohexanone (3k)
(3S, 4R)-3-Hydroxy-5-nitro-4-phenylpentan-2-one (4d)
[a]D20 5 2 73.8 (c 0.26, CH2Cl2), 1H NMR (400 MHz, CDCl3): d 5 8.16
(s, 1H), 7.86 (d, J 5 8.0 Hz, 1H), 7.78 (d, J 5 8.0 Hz, 1H), 7.60–7.36 (m,
4H), 5.07 (dd, J 5 12.8, 4.4 Hz, 1H), 4.91 (dd, J 5 12.8, 9.6 Hz, 1H), 4.76
(s, 1H), 2.87 (s, 1H), 2.53–2.38 (m, 2H), 2.11–2.05 (m, 1H), 1.73–1.50 (m,
4H), 1.30–1.20 (m, 1H). The enantiometric excess was determined by
HPLC with a Chiralpak AS-H column (hexane:2-propanol 5 70:30, k 5
208 nm, 0.7 ml/min); tR (minor enantiomer) 5 14.64 min, tR (major
enantiomer) 5 20.58 min, 93% ee.
1H NMR (400 MHz, CDCl3): d 5 7.43–7.17 (m, 5H 1 3H*), 5.03 (dd, J
5 13.3, 8.0 Hz, 1H), 4.82 (dd, J 5 13.6, 6.4 Hz, 0.57H*), 4.73 (dd, J 5
13.6, 7.2 Hz, 1H), 4.65 (dd, J 5 13.6, 8.0 Hz, 0.57H*), 4.53–4.51 (m, 1H),
4.40–4.38 (m, 0.5H*), 4.03 (td, J 5 7.6, 2.8 Hz, 1H), 3.85–3.81 (m,
0.57H*), 3.72–3.71 (m, 1H 1 0.56H*), 2.18 (s, 3H), 2.07 (s, 1.6H*). The
enantiometric excess was determined by HPLC with a Chiralpak AD-H
column (hexane:2-propanol 5 90:10, k 5 220 nm, 1.0 ml/min); (major
Chirality DOI 10.1002/chir